Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
Shares of Recursion Pharmaceuticals rose Tuesday morning after the company said slashing its workforce by 20% will extend its cash runway to the end of 2027. Shares were trading more than 10% higher ...
CineFridays at the VoxHouse will present some of the Frederick festival-favorite live action shorts in its free Festival Flashback series on May 9. The aim of this particular series is to provide some ...
Hosted on MSN
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and 9 ...
The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. “Affinity was an open problem for decades,” Barzilay ...
Camera lens names might look like gibberish, but they have meaning. We decode the naming conventions of 11 lens manufacturers, including Canon, Fujifilm, Nikon, and other major brands. Images, and the ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Recursion Thinks AI Can Lower The High Failure Rate Of New Pharmaceutical Drugs Video unavailable Chris Gibson, Cofounder and CEO of Recursion, lays out how his company is building the biological data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results